Skip to content

Subarachnoid anesthesia combined with propofol TCI sedation: a more favorable choice for posterior total hip arthroplasty

Subarachnoid anesthesia combined with propofol TCI sedation: a more favorable choice for posterior total hip arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013461
Enrollment
Unknown
Registered
2017-11-20
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

femoral head necrosis/hip osteoarthritis

Interventions

group CSEA:CSEA
general anesthesia group:general anesthesia
group PT: subarachnoid anesthesia in conjunction with propofol TCI sedation

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: age>18 years old, ASA I-III underwent posterior total hip arthroplasty

Exclusion criteria

Exclusion criteria: 1. cardiac, pulmonary, renal and hepatic disorders; 2. long-term administration of NSAIDs; 3. coagulation disorders, and platelet count; 4. history of deep vein thrombosis (DVT) or pulmonary embolism; 5. hematological disorder, some peripheral vascular disease, such as K-T syndrome, and anaemia; 6. ankylosing spondylitis.

Design outcomes

Primary

MeasureTime frame
intraoperative blood loss;autologous blood transfusion;allogeneic blood transfusion;duration in PACU;postoperative VAS score;the patient satisfaction degree;the hospitalization length;postoperative headache and lower back pain;

Secondary

MeasureTime frame
postoperative nausea and vomiting;DVT of the lower extremity;onset of postoperative functional exercise;

Countries

China

Contacts

Public ContactGeng Wang

Beijing Jishuitan Hospital

w_geng@163.com+86 13910676672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026